Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad A Oghabian

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Nanotechnology|December 25, 2010
Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspectiveMohammad A Oghabian, Nima M Farahbakhsh
Neuroreport|March 1, 2019
Brain microstructural abnormalities correlate with KCC2 downregulation in refractory epilepsyZeinab Gharaylou, Mohammad A Oghabian, Zahra Azizi, et al.
International Journal of Medical Sciences|July 12, 2005
Application of small angle X-ray scattering (SAXS) for differentiation between normal and cancerous breast tissueVahid Changizi, Mohammad A Oghabian, Robert Speller, et al.
International Journal of Biological Macromolecules|February 9, 2017
Chitosan coated tungsten trioxide nanoparticles as a contrast agent for X-ray computed tomographyMehdi Firouzi, Reza Poursalehi, Hamid Delavari H, et al.
Nuclear Medicine Communications|July 30, 2013
Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancersSaeed Shanehsazzadeh, Mohammad A Oghabian, Afsaneh Lahooti, et al.
Molecular Imaging and Biology|February 7, 2014
Breast cancer cells imaging by targeting methionine transporters with gadolinium-based nanoprobeBita Mehravi, Mehdi Shafiee Ardestani, Maryam Damercheli, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Nanotechnology|December 25, 2010
Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspectiveMohammad A Oghabian, Nima M Farahbakhsh
Neuroreport|March 1, 2019
Brain microstructural abnormalities correlate with KCC2 downregulation in refractory epilepsyZeinab Gharaylou, Mohammad A Oghabian, Zahra Azizi, et al.
International Journal of Medical Sciences|July 12, 2005
Application of small angle X-ray scattering (SAXS) for differentiation between normal and cancerous breast tissueVahid Changizi, Mohammad A Oghabian, Robert Speller, et al.
International Journal of Biological Macromolecules|February 9, 2017
Chitosan coated tungsten trioxide nanoparticles as a contrast agent for X-ray computed tomographyMehdi Firouzi, Reza Poursalehi, Hamid Delavari H, et al.
Nuclear Medicine Communications|July 30, 2013
Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancersSaeed Shanehsazzadeh, Mohammad A Oghabian, Afsaneh Lahooti, et al.
Molecular Imaging and Biology|February 7, 2014
Breast cancer cells imaging by targeting methionine transporters with gadolinium-based nanoprobeBita Mehravi, Mehdi Shafiee Ardestani, Maryam Damercheli, et al.
Pageof 1